Series B funding round for Q32 Bio raising $60M in October 2020
Series B funding round for Q32 Bio raising $60M in October 2020
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
OrbiMedLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$106M
Top Valuation
-
Q32 Bio raised $60M in a Series B round.
The round was announced on 10/01/20.
The round was led by Acorn Bioventures, OrbiMed.